Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Qihuang Medicine Clinical Research Center is a prominent Chinese Contract Research Organization (CRO) that provides end-to-end clinical trial services for pharmaceuticals, biologics, and medical devices. Founded in 2001 and headquartered in Beijing, the center specializes in Phase I through IV clinical trials, bioequivalence studies, and regulatory submission strategies. It is particularly well-regarded for its expertise in the clinical evaluation and modernization of Traditional Chinese Medicine (TCM). The organization offers integrated solutions including medical writing, data management, and statistical analysis to ensure compliance with NMPA standards. Beijing Qihuang serves a diverse clientele ranging from domestic Chinese pharmaceutical firms to multinational corporations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Qihuang Medicine Clinical Research Center.